Outset Medical Steadies Ship with Strong Q2 | Business and Finance News

Outset Medical is turning things around with a solid Q2 performance, hitting $31.6M in revenue and a 42% gross margin—signaling operational efficiency. They’re staying on track for their full-year forecast of $125–130M, while expanding their footprint with record implementations and customer adoption of the Tablo system. A major win: training 100 nurses to deliver 1,000 treatments in just 60 days. Customers are raving, giving them an 8.8/10 recommendation score. The big news? A $40M refresh deal with HCA Healthcare through 2028—their first major refresh win, unlocking potential for 3,000 consoles and $150M+ in future revenue. They’re also rolling out a next-gen Tablo system with upgraded hardware, software, and security, currently in pilot. New leadership in commercial sales signals a push for scalable growth. Outset’s sights are set on profitability and reshaping dialysis care with smarter, lower-cost tech for a massive, underserved market. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/512a6be969edb0e2